Chemoimmunotherapy Shows Promise in MSS Colorectal Cancer: Pooled Analysis Insights
Pooled analysis from MEDITREME and METIMMOX studies indicates that first-line chemoimmunotherapy may effectively treat metastatic microsatellite stable colorectal cancer.